share

Trial Drug Reduces Recurrence of Genetic Breast Cancer in Women, New Study Shows

The BRCA1 and BRCA2 gene mutations account for about 10% of all breast cancer cases globally.

published
Jun 4, 2021
breast cancer drug
Image Credit: Radiopaedia
Share
Tags
AuthorRohitha Naraharisetty

Rohitha Naraharisetty is a Senior Associate Editor at The Swaddle. She writes about the intersection of gender, caste, social movements, and pop culture. She can be found on Instagram at @rohitha_97 or on Twitter at @romimacaronii.

Related